Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084)
- Status
- COMPLETED
- Phase
- PHASE1
A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
- Status
- UNKNOWN
- Phase
- PHASE2
The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
- Status
- COMPLETED
- Phase
- NA
A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations
- Status
- COMPLETED
- Phase
- NA
A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine
- Status
- SUSPENDED
- Phase
- PHASE2
A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients
- Status
- COMPLETED
- Phase
- PHASE3
The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz
- Status
- COMPLETED
- Phase
- NA
Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia
- Status
- COMPLETED
- Phase
- PHASE4
The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients
- Status
- COMPLETED
- Phase
- NA
Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients
- Status
- COMPLETED
- Phase
- NA
A Study of L-735,524 in HIV-Positive Children and Adolescents
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily
- Status
- UNKNOWN
- Phase
- PHASE2
A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors
- Status
- COMPLETED
- Phase
- PHASE2
Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir
- Status
- COMPLETED
- Phase
- PHASE3
A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC
- Status
- COMPLETED
- Phase
- PHASE3